Last update :
03/05/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Antiviral   Cidofovir  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Cidofovir France, Spain
Sidovis Switzerland
Vistide Australia, Austria, Belgium, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Luxembourg, Netherlands, New Zealand, Poland, Portugal, Romania, Sweden, Switzerland, United States of America
Stability in solutions   Injection   Stability in solutions : Cidofovir     
Container Solvent Concentration Temperature Storage Duration of stability References
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,21 & 8,12 mg/ml 2-8°C Protect from light
24 Hour
1
Level of evidence C+
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,21 & 8,12 mg/ml 30°C Light
24 Hour
1
Level of evidence C+
Polyvinyl chloride Sodium chloride 0,9% 0,2 & 8,1 mg/ml -20°C Protect from light
5 Day
71
Level of evidence A+
Polyvinyl chloride Sodium chloride 0,9% 0,2 & 8,1 mg/ml 2-8°C Protect from light
5 Day
71
Level of evidence A+
Polypropylene and polyethylene NaCl 0,9% or Glucose 5% 0,21 & 8,12 mg/ml 2-8°C Protect from light
24 Hour
1
Level of evidence C+
Polypropylene and polyethylene NaCl 0,9% or Glucose 5% 0,21 & 8,12 mg/ml 30°C Light
24 Hour
1
Level of evidence C+
Polypropylene and polyethylene Sodium chloride 0,9% 0,2 & 8,1 mg/ml -20°C Protect from light
5 Day
71
Level of evidence A+
Polypropylene and polyethylene Sodium chloride 0,9% 0,2 & 8,1 mg/ml 2-8°C Protect from light
5 Day
71
Level of evidence A+
Polypropylen Syringe Sodium chloride 0,9% 6.25 mg/ml 25°C With or without light
150 Day
1989
Level of evidence D
Polypropylen Syringe Sodium chloride 0,9% 6.25 mg/ml 32°C With or without light
150 Day
1989
Level of evidence D
Polypropylen Syringe Sodium chloride 0,9% 6.25 mg/ml 4°C Protect from light
150 Day
1989
Level of evidence D
  Mentions Légales